BR9704879A - Composição de vacina e uso de um vírus cav vivo - Google Patents
Composição de vacina e uso de um vírus cav vivoInfo
- Publication number
- BR9704879A BR9704879A BR9704879A BR9704879A BR9704879A BR 9704879 A BR9704879 A BR 9704879A BR 9704879 A BR9704879 A BR 9704879A BR 9704879 A BR9704879 A BR 9704879A BR 9704879 A BR9704879 A BR 9704879A
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine composition
- inactivated
- live cav
- vaccines
- cav virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
- C12N2720/12234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96202708 | 1996-09-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9704879A true BR9704879A (pt) | 1998-10-27 |
Family
ID=8224440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9704879A BR9704879A (pt) | 1996-09-27 | 1997-09-26 | Composição de vacina e uso de um vírus cav vivo |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5914113A (pt) |
| EP (1) | EP0838222B1 (pt) |
| JP (1) | JP4108796B2 (pt) |
| KR (1) | KR100447297B1 (pt) |
| AT (1) | ATE274355T1 (pt) |
| AU (1) | AU715947B2 (pt) |
| BR (1) | BR9704879A (pt) |
| CA (1) | CA2216410C (pt) |
| DE (1) | DE69730393T2 (pt) |
| DK (1) | DK0838222T3 (pt) |
| ES (1) | ES2227651T3 (pt) |
| HU (1) | HU223734B1 (pt) |
| PT (1) | PT838222E (pt) |
| ZA (1) | ZA978434B (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1140152B1 (en) * | 1998-12-21 | 2003-08-06 | Akzo Nobel N.V. | Method to produce inactivated w/o emulsion adjuvated vaccines |
| US7026155B2 (en) | 1999-02-02 | 2006-04-11 | Regents Of The University Of California | Method of reducing bacterial proliferation |
| JP2001275664A (ja) * | 2000-02-29 | 2001-10-09 | Akzo Nobel Nv | 低い病原性のニワトリ貧血ウイルス |
| US6593134B1 (en) * | 2000-03-10 | 2003-07-15 | Cornell Research Foundation, Inc. | Method of propagating chicken infectious anemia virus |
| US20040208842A1 (en) * | 2001-09-18 | 2004-10-21 | Ritchie Branson W. | Antimicrobial cleansing compositions and methods of use |
| US20070003508A1 (en) | 2005-07-01 | 2007-01-04 | Wooley Richard E | Methods and compositions for promoting wound healing |
| US20040151765A1 (en) * | 2001-09-18 | 2004-08-05 | Ritchie Branson W. | Methods and compositions for wound management |
| US6861410B1 (en) * | 2002-03-21 | 2005-03-01 | Chiron Corporation | Immunological adjuvant compositions |
| US7217420B2 (en) * | 2002-07-13 | 2007-05-15 | The University Of Georgia Research Foundation, Inc. | Mycoplasma gallisepticum formulation |
| US20070185202A1 (en) * | 2004-03-03 | 2007-08-09 | University Of Georgia Research Foundation, Inc. | Methods and compositions for ophthalmic treatment of fungal and bacterial infections |
| BR112012012921A2 (pt) * | 2009-12-01 | 2016-10-25 | Intervet Int Bv | uso de uma quantidade imunogênica de um vírus da doença de newcastle inativado e um adjuvante, composição farmacêutica, e, kit de partes |
| CA2725435C (en) | 2009-12-15 | 2023-01-03 | University Of Saskatchewan | Vaccines for inclusion body hepatitis |
| WO2015042423A2 (en) * | 2013-09-19 | 2015-03-26 | Zoetis Llc | Vaccine |
| UA126562C2 (uk) * | 2016-06-02 | 2022-11-02 | Зоетіс Сервісіз Ллс | Вакцина для домашньої птиці проти інфекційного бронхіту |
| CN107603958A (zh) * | 2017-09-29 | 2018-01-19 | 天津农学院 | 融合表达TM‑1基因和gD基因重组腺病毒的构建方法及重组腺病毒和应用 |
| CN110433288A (zh) * | 2018-05-03 | 2019-11-12 | 乐斯福公司 | 试剂盒和β-葡聚糖提取物在禽类动物免疫增强中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2170708A (en) * | 1937-04-29 | 1939-08-22 | Atlas Tack Corp | Eyelet |
| FR2801M (fr) * | 1963-05-20 | 1964-09-21 | Pierre Lepine | Vaccins dits interférentiels contre les maladies a virus. |
| IL74289A (en) * | 1985-02-10 | 1989-02-28 | Israel State | Vaccine system comprising a live-non-virulent vaccine and an adjuvant |
| US5037650A (en) * | 1988-03-08 | 1991-08-06 | Akzo N.V. | Live combination vaccine |
| FR2667245B1 (fr) * | 1990-10-01 | 1992-11-06 | Rhone Merieux | Association vaccinale contre les pathogenes infectieux. |
| ZA927014B (en) * | 1991-09-20 | 1993-03-19 | Akzo Nv | Chicken anaemia agent vaccine. |
| US5686077A (en) * | 1991-09-20 | 1997-11-11 | Akzo Nobel N.V. | Methods of immunization of poultry with vaccines against chicken anemia agent (CAA) |
| CA2181862C (en) * | 1995-08-01 | 2009-12-22 | Carla Christina Schrier | Mild newcastle disease virus vaccine |
| DE69632235T2 (de) * | 1995-10-18 | 2004-08-26 | Akzo Nobel N.V. | Newcastle-Krankheitsvirus-Kombinationsimpfstoff |
| FR2751225B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
-
1997
- 1997-09-18 ZA ZA9708434A patent/ZA978434B/xx unknown
- 1997-09-24 PT PT97202926T patent/PT838222E/pt unknown
- 1997-09-24 DK DK97202926T patent/DK0838222T3/da active
- 1997-09-24 EP EP97202926A patent/EP0838222B1/en not_active Expired - Lifetime
- 1997-09-24 DE DE69730393T patent/DE69730393T2/de not_active Expired - Lifetime
- 1997-09-24 ES ES97202926T patent/ES2227651T3/es not_active Expired - Lifetime
- 1997-09-24 AT AT97202926T patent/ATE274355T1/de not_active IP Right Cessation
- 1997-09-25 CA CA002216410A patent/CA2216410C/en not_active Expired - Fee Related
- 1997-09-26 US US08/939,046 patent/US5914113A/en not_active Expired - Lifetime
- 1997-09-26 BR BR9704879A patent/BR9704879A/pt not_active IP Right Cessation
- 1997-09-26 KR KR1019970048971A patent/KR100447297B1/ko not_active IP Right Cessation
- 1997-09-26 HU HU9701586A patent/HU223734B1/hu not_active IP Right Cessation
- 1997-09-26 AU AU39260/97A patent/AU715947B2/en not_active Ceased
- 1997-09-26 JP JP26245597A patent/JP4108796B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10114678A (ja) | 1998-05-06 |
| ZA978434B (en) | 1998-03-26 |
| JP4108796B2 (ja) | 2008-06-25 |
| ES2227651T3 (es) | 2005-04-01 |
| ATE274355T1 (de) | 2004-09-15 |
| CA2216410C (en) | 2007-04-17 |
| HU9701586D0 (en) | 1997-11-28 |
| EP0838222A1 (en) | 1998-04-29 |
| AU715947B2 (en) | 2000-02-10 |
| CA2216410A1 (en) | 1998-03-27 |
| EP0838222B1 (en) | 2004-08-25 |
| DE69730393D1 (de) | 2004-09-30 |
| HU223734B1 (hu) | 2004-12-28 |
| KR19980025002A (ko) | 1998-07-06 |
| MX9707402A (es) | 1998-06-30 |
| AU3926097A (en) | 1998-04-02 |
| HUP9701586A3 (en) | 2001-06-28 |
| KR100447297B1 (ko) | 2004-11-06 |
| US5914113A (en) | 1999-06-22 |
| DK0838222T3 (da) | 2004-12-13 |
| PT838222E (pt) | 2004-11-30 |
| DE69730393T2 (de) | 2005-09-01 |
| HUP9701586A2 (hu) | 1998-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9704879A (pt) | Composição de vacina e uso de um vírus cav vivo | |
| DE69632235D1 (de) | Newcastle-Krankheitsvirus-Kombinationsimpfstoff | |
| NO20001768D0 (no) | Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav | |
| CY1105010T1 (el) | Πεπτιδια που λαμβανονται απο τη συνδεση (g) πρωτεϊνης του αναπνευστικου συνκυτιακου ιου | |
| DE69016956D1 (de) | Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor. | |
| NO912825D0 (no) | Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper. | |
| ATE377428T1 (de) | Rotavirus-impfstoff | |
| DE69531793D1 (de) | Immunogene zubereitungen | |
| CY1107910T1 (el) | Αντιγονα erysipelothrix rhusiopathiae και συνθεσεις εμβολιων | |
| DE68920345T2 (de) | Lebendes Kombinationsvakzin. | |
| MX9301736A (es) | Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. | |
| PT729509E (pt) | Vacina contra papeira contendo uma estirpe do virus jerryl-lynn | |
| WO2002024147A3 (en) | Avian pneumovirus vaccine | |
| GB9303681D0 (en) | Vaccines | |
| DE216901T1 (de) | Immunogenes antigen-traeger-proteinkonjugat zur verwendung in impfstoffen gegen malaria. | |
| FR2698271B1 (fr) | Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination. | |
| FR2730936B1 (fr) | Vaccin presentant une immunogenicite accrue | |
| RU95121713A (ru) | Способ одновременной профилактики менингококковой инфекции, дифтерии, брюшного тифа, натуральной оспы, гриппа и вирусного гепатита |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/04/2008, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B24C | Patent annual fee: request for for restoration |
Free format text: REFERENTE A 15A ANUIDADE(S), CONFORME ART. 87 DA LPI 9.279. |
|
| B24H | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi) | ||
| B24F | Patent annual fee: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2258 DE 15/04/2014 POR TER SIDO INDEVIDA. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 15A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2606 DE 15-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |